Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib

BACKGROUND: Patients with immune thrombocytopenia (ITP) are at risk of bleeding and, paradoxically, thromboembolic events (TEEs), irrespective of thrombocytopenia. The risk of thrombosis is increased by advanced age, obesity, and prothrombotic comorbidities: cancer, hyperlipidemia, diabetes, hyperte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Hematol
Principais autores: Cooper, Nichola, Altomare, Ivy, Thomas, Mark R., Nicolson, Phillip L. R., Watson, Steve P., Markovtsov, Vadim, Todd, Leslie K., Masuda, Esteban, Bussel, James B.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111531/
https://ncbi.nlm.nih.gov/pubmed/33995988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20406207211010875
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados